Rosette formation by peripheral lymphocytes. II. Inhibition of the phenomenon.
D000372:Agglutination Tests; D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000937:Antigen-Antibody Reactions / Q000187:drug effects*; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001379:Azathioprine / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects; D003165:Complement System Proteins; D003486:Cyanides / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D004912:Erythrocytes / Q000276:immunology*; D006084:Graft Rejection; D000882:Haplorhini; D006736:Horses; D006358:Hot Temperature; D006801:Humans; D007115:Immunization Schedule; D037102:Lectins; D008214:Lymphocytes / Q000276:immunology*; D015122:Mercaptopurine / Q000494:pharmacology; D008628:Mercury / Q000494:pharmacology; D009942:Organometallic Compounds / Q000494:pharmacology; D010215:Papio; D010434:Pepsin A; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D000888:Antibodies, Anti-Idiotypic; D000961:Antilymphocyte Serum; D003486:Cyanides; D037102:Lectins; D009942:Organometallic Compounds; D003165:Complement System Proteins; D015122:Mercaptopurine; D010434:Pepsin A; D008628:Mercury; D001379:Azathioprine